The Melanoma Nursing Initiative – Home › Forums › Immunotherapy › Dosing and administration › Opdivo dosing changes › Reply To: Opdivo dosing changes
March 24, 2018 at 12:37 pm
#4770
We are currently moving most of our patients on both adjuvant and maintained Nivolumab to 4 weeks. It is easier on the patient from a time and financial perspective. They don’t have to take time off of work, find childcare, or have to pay Travel expenses as often. We are keeping patients on he 2 week schedule only if they are complicated or may need a little more frequent visits/monitoring.